The Department of Surgery doesn’t just excel in the operating room. Through our extensive and innovative research programs, we are also focused on the development of new techniques and therapies that promote better outcomes and improve the quality of life for patients following surgery.
As part of that goal, the department’s surgeons are involved in groundbreaking clinical trials. In addition to their research value, clinical trials may also give patients access to new treatments that are not available anywhere else.
Learn more about our current clinical trials below or visit the Joint Clinical Trials Office at Weill Cornell Medicine and NewYork-Presbyterian.
This study is for men and women who participate in the YMCA's Diabetes Prevention Program (YMCA's DPP) and have been diagnosed with non-alcoholic fatty liver disease (NAFLD). There will be no administration of study drug.
1. Men and women over 18 years of age.
2. Diagnosed with Non-alcoholic Fatty liver disease.
3. Detailed eligibility reviewed when contacting the study team.
The purpose of this study is to determine whether a non-invasive monitoring device that uses a technology called near-infrared spectroscopy can be used to monitor the amount of blood flow to your spinal cord during surgery.
Patients undergoing descending thoracic or thoracoabdominal aortic surgery for aneurysm or aortic dissection.
Detailed eligibility criteria will be reviewed when you contact the study team.
Catheter ablation has emerged as an effective therapy for patients with atrial fibrillation (AF) in whom medications are not effective. The pulmonary veins (PVs) are the most common source of triggers of AF. Hence, the central approach in catheter ablation of atrial fibrillation involves creating
- All patients undergoing catheter ablation of atrial fibrillation
- Between the ages of 18 and 85
- More detailed eligibility discussed when you contact the study team